United States · FDA National Drug Code directory
ACETAMINOPHEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-183_5447f567-0cef-ae0a-e063-6394a90ad867
- Product NDC
- 62207-183
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- ACETAMINOPHEN
- Labeler
- Granules India Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190418
- Source listing expiry
- 20271231
Source-listed ingredients
- ACETAMINOPHEN — 650 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 BOX (62207-183-34) / 5 TABLET, EXTENDED RELEASE in 1 POUCH · 62207-183-34
- 6 POUCH in 1 BOX (62207-183-35) / 3000 TABLET, EXTENDED RELEASE in 1 POUCH · 62207-183-35
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62207-183-49) · 62207-183-49
- 1 BOTTLE in 1 CARTON (62207-183-51) / 10 TABLET, EXTENDED RELEASE in 1 BOTTLE · 62207-183-51
- 1 POUCH in 1 BOX (62207-183-87) / 1 TABLET, EXTENDED RELEASE in 1 POUCH · 62207-183-87
- 40000 TABLET, EXTENDED RELEASE in 1 DRUM (62207-183-97) · 62207-183-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →